![](/img/cover-not-exists.png)
A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucrose
M. RUBINGER, D. LILLICRAP, G. E. RIVARD, J. TEITEL, M. CARCAO, C. HENSMAN, I. WALKER, THE ASSOCIATION OF HEMOPHILIA CLINIC DIRECTORS OF CANADA (AHCDC)Volume:
14
Year:
2008
Language:
english
Pages:
6
DOI:
10.1111/j.1365-2516.2007.01634.x
File:
PDF, 94 KB
english, 2008